DSD-T365

Androgen insensitivity syndrome · 45,X/46,XY · DSD-T365

DSD-T365 · Sex chromosome DSD · 2024 · Automated translation

Karyotype 45,X/46,XY · Phenotypes HPO:0000028, HPO:0000054, Micropenis (HP:0000054), Cryptorchidism (HP:0000028)

Partial androgen insensitivity syndrome (PAIS, mild phenotype, AR c.2041A>G).

Case fields and evidence

Category

Androgen insensitivity syndrome

Karyotype

45,X/46,XY

Phenotypes

Micropenis (HP:0000054); Cryptorchidism (HP:0000028)

Diagnosis

Partial androgen insensitivity syndrome (PAIS, mild phenotype, AR c.2041A>G).

Follow-up

Reduction mammoplasty 2 years later; no outpatient follow-up, self-reported no change in penile length or testicular volume; currently attending vocational school.

General phenotype

Normal-appearing male phenotype, thin build; gynecomastia.

Imaging

Pelvic ultrasound showed no intrapelvic gonads; pituitary MRI, adrenal CT, and pelvic ultrasound all unremarkable.

Laboratory findings

Progesterone 0.43 ng/mL (0.06-6.09), FSH 2.83 mIU/mL (1.52-10.30), LH 7.23 mIU/mL (0.79-7.47), testosterone 5.21 ng/mL (0.20-6.60), SHBG 27.3 nmol/L (8.6-64.2); calculated free testosterone 424.0 pmol/L and bioavailable testosterone 9.950 nmol/L (higher than peers); thyroid function, β-HCG, IGF-1, IGFBP-3, prolactin, and estradiol normal.

Management

Testosterone undecanoate 40 mg orally twice daily (discontinued after 1 month due to difficulty obtaining the medication, with the clinical team's agreement, given normal penile length and testicular volume); reduction mammoplasty performed 2 years later because of breast enlargement.

Pathology

Not reported in the original article

Evidence level

See source

Clinical history

See source

Growth and development

See source

External genital examination

See source

Genetics

See source

Cite this resource

DSD Research Library | Androgen insensitivity syndrome · 45,X/46,XY · DSD-T365 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T365?version=v1.4.0